CPC
BLUE

Cookson Peirce & Co’s bluebird bio BLUE Stock Holding History

Cookson Peirce & Co’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$69K – 209
2022
Q4 		$69K Buy
+500
New +$70.4K ﹤0.01% 199
2019
Q2 		– Sell
-322
Closed -$656K – 154
2019
Q1 		$656K Buy
+322
New +$567K 0.06% 94

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Cookson Peirce & Co's BLUE Position: Q1 2023 in Review

Cookson Peirce & Co sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 500 shares — an estimated $69K sold.

Cookson Peirce & Co first reported a position in BLUE in Q1 2019 and held it in 2 quarters. The position peaked at $656K in Q1 2019. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Cookson Peirce & Co reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Cookson Peirce & Co sold 500 bluebird bio shares in Q1 2023, an estimated $69K.
  • Cookson Peirce & Co first reported a position in bluebird bio in Q1 2019 and held it in 2 quarters.
  • Cookson Peirce & Co's bluebird bio position peaked at $656K in Q1 2019.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Cookson Peirce & Co's 13F filing for Q1 2023, filed 3 May 2023.